Alligator Bioscience AB Stock London S.E.
Stocks
0RK9
SE0024173637
Biotechnology & Medical Research
OTC Markets Traded|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.1660 SEK | -48.27% |
|
-11.76% | -47.30% |
| 06-08 | Alligator partner Henlius doses first patients in HLX22 study | FW |
| 06-08 | Alligator Bioscience Comments on Henlius Update on Global Phase 3 Trial with Hlx22 | CI |
| Market Cap | 107M 11.33M 9.78M 8.99M 8.46M 15.9M 1.07B 16.03M 41.47M 525M 42.54M 41.63M 1.82B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 107M 11.33M 9.78M 8.99M 8.46M 15.9M 1.07B 16.03M 41.47M 525M 42.54M 41.63M 1.82B | EV / Sales 2026 * |
2.67x | EV / Sales 2027 * | 18.1x |
| Free-Float |
71.01% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Alligator Bioscience AB
| 1 day | -2.12% | ||
| 1 week | -11.76% | ||
| Current month | -17.07% | ||
| 1 month | -26.26% | ||
| 3 months | -10.26% | ||
| 6 months | -46.65% | ||
| Current year | -47.30% |
| 1 week | 0.17 |  | 0.32 |
| 1 month | 0.17 | | 0.32 |
| Current year | 0.16 | | 0.42 |
| 1 year | 0.16 | | 6.77 |
| 3 years | 0.16 | | 1,508 |
| 5 years | 0.16 | | 3,509.77 |
| 10 years | 0.16 | | 34,002.21 |
| Manager | Title | Age | Since |
|---|---|---|---|
Søren Bregenholt
CEO | Chief Executive Officer | 55 | 2021-05-31 |
Johan Gileus
DFI | Director of Finance/CFO | 61 | 2024-08-11 |
Tom Moore
CTO | Chief Tech/Sci/R&D Officer | - | 2025-03-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 55 | - | |
| Director/Board Member | 64 | 2021-05-31 | |
Denise Goode
BRD | Director/Board Member | 68 | 2022-05-08 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -48.27% | -11.76% | - | - | 11.33M | |
| -0.56% | -0.51% | -12.53% | -10.84% | 43.44B | |
| +1.39% | +6.90% | +299.50% | +521.18% | 33.54B | |
| -2.81% | -8.55% | +7.10% | -22.96% | 28.48B | |
| +2.70% | +4.15% | +7.24% | +41.50% | 29.2B | |
| +0.06% | +4.36% | +13.31% | +21.11% | 25.34B | |
| +1.50% | +8.45% | - | - | 14.36B | |
| -0.18% | -3.82% | +50.96% | +102.83% | 13.05B | |
| -0.03% | -2.83% | +3.34% | +4.20% | 12.67B | |
| -0.85% | +0.15% | +99.76% | +80.01% | 12.28B | |
| Average | -0.09% | +1.33% | +58.58% | +92.13% | 23.6B | |
| Weighted average by Cap. | +0.14% | +1.35% | +61.54% | +103.44% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 39.9M 4.24M 3.66M 3.37M 3.17M 5.95M 401M 6M 15.53M 197M 15.93M 15.59M 680M | 5.9M 628K 542K 498K 469K 881K 59.24M 888K 2.3M 29.07M 2.36M 2.31M 101M |
| Net income | -36.3M -3.86M -3.33M -3.06M -2.88M -5.42M -364M -5.46M -14.13M -179M -14.49M -14.18M -619M | -69.9M -7.44M -6.42M -5.9M -5.55M -10.43M -702M -10.52M -27.21M -344M -27.91M -27.31M -1.19B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-12-18 | 0.3209 kr | -99.99% | 10,156 |
| 26-06-17 | 0.1696 kr | -5.25% | 18,690 |
| 26-06-12 | 0.1790 kr | -3.97% | 40,000 |
| 26-06-11 | 0.1864 kr | -3.02% | 38,138 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- ATORX Stock
- 0RK9 Stock
Select your edition
All financial news and data tailored to specific country editions
